Given the frequency at which abnormalities in EGFR signaling are present in human breast cancer and observations of how these changes influence tumor cell survival, migration, metastasis, and angiogenesis, EGFR has been an attractive target for therapeutic manipulation. The gene discussed is EGFR; the disease is breast carcinoma.